PCR 머신 시장 보고서 : 동향, 예측 및 경쟁 분석(2035년)

The future of the global PCR machine market looks promising with opportunities in the clinical and non-clinical markets. The global PCR machine market is expected to reach an estimated $3.5 billion by 2035 with a CAGR of 6.5% from 2026 to 2035. The major drivers for this market are the increasing demand for genetic testing, the rising adoption of diagnostic technologies, and the growing focus on infectious disease detection.

• Lucintel forecasts that, within the type category, real-time PCR is expected to witness the highest growth over the forecast period.
• Within the application category, clinical is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the PCR Machine Market

The PCR machine market is experiencing rapid growth driven by technological advancements, increasing applications in healthcare and research, and a rising demand for rapid diagnostic tools. As laboratories and medical facilities seek more efficient, accurate, and cost-effective solutions, the market is evolving with innovative features and expanding applications. The integration of automation, digitalization, and portable devices is further transforming the landscape, making PCR technology more accessible and versatile. These developments are not only enhancing diagnostic capabilities but also broadening the scope of research and personalized medicine, ultimately reshaping the competitive dynamics and growth trajectory of the PCR machine industry.

• Technological Innovation: The market is witnessing continuous advancements in PCR technology, including digital PCR, real-time PCR, and multiplex PCR. These innovations improve sensitivity, specificity, and speed, enabling more accurate diagnostics and research outcomes. Automated systems and user-friendly interfaces are making PCR machines more accessible to non-specialist users, expanding their application scope. The integration of AI and machine learning is further optimizing data analysis, reducing errors, and increasing throughput. These technological improvements are driving market growth by meeting the increasing demand for precise and rapid testing solutions across healthcare, agriculture, and environmental sectors.
• Rising Demand for Point-of-Care Testing: The need for rapid, on-site diagnostic testing is fueling the growth of portable and benchtop PCR machines. These compact devices facilitate quick decision-making in clinical settings, emergencies, and remote locations, reducing reliance on centralized laboratories. The COVID-19 pandemic significantly accelerated this trend, highlighting the importance of decentralized testing. As healthcare systems prioritize faster diagnosis and treatment, the demand for portable PCR solutions is expected to surge, expanding market reach into primary care, field diagnostics, and resource-limited regions.
• Expansion in Healthcare and Research Applications: PCR machines are increasingly used beyond traditional diagnostics, including personalized medicine, genetic testing, infectious disease detection, and cancer research. The growing emphasis on early diagnosis and targeted therapies is boosting demand for advanced PCR technologies. Additionally, the expanding research activities in genomics, microbiology, and biotechnology are driving the need for high-throughput and versatile PCR systems. This diversification of applications is broadening the market scope and encouraging manufacturers to develop specialized and customizable PCR solutions to meet diverse industry needs.
• Integration of Automation and Digital Technologies: Automation is transforming PCR workflows by reducing manual intervention, minimizing errors, and increasing efficiency. Automated sample preparation, data analysis, and reporting streamline laboratory processes, saving time and resources. Digital technologies, including cloud-based data management and remote monitoring, enhance collaboration and data security. These integrations are particularly valuable in high-volume testing environments, such as hospitals and research institutions, where speed and accuracy are critical. The adoption of automation and digital tools is making PCR testing more reliable, scalable, and cost-effective, thereby expanding its adoption across various sectors.
• Market Expansion and Strategic Collaborations: The PCR machine market is witnessing significant expansion into emerging markets, driven by increasing healthcare infrastructure and awareness. Companies are forming strategic alliances, collaborations, and partnerships to develop innovative products and expand distribution channels. Mergers and acquisitions are also common, aimed at enhancing technological capabilities and market presence. Additionally, government initiatives and funding for infectious disease control and genomic research are supporting market growth. These strategic moves are enabling companies to penetrate new markets, diversify product portfolios, and accelerate innovation, ultimately fueling the overall growth of the PCR machine industry.

In summary, these trends are collectively reshaping the PCR machine market by enhancing technological capabilities, expanding application areas, and increasing accessibility. The focus on automation, portability, and strategic growth initiatives is making PCR technology more efficient, versatile, and widespread. As a result, the market is poised for sustained growth, driven by the increasing demand for rapid, accurate, and accessible diagnostic and research solutions across the globe.

Recent Developments in the PCR Machine Market

The PCR machine market is experiencing rapid growth driven by technological advancements, increasing demand for diagnostic testing, and expanding applications across healthcare, research, and industrial sectors. Innovations in automation, miniaturization, and data integration are enhancing efficiency and accuracy. The COVID-19 pandemic has further accelerated adoption, highlighting the importance of rapid and reliable testing solutions. As the market evolves, key opportunities are emerging that promise to reshape the landscape and expand the reach of PCR technology globally.

• Growth in Healthcare Diagnostics: The rising prevalence of infectious diseases and genetic disorders is fueling demand for PCR machines. Healthcare providers seek faster, more accurate diagnostic tools to improve patient outcomes. Technological innovations have led to portable, user-friendly PCR systems, enabling point-of-care testing. This growth enhances early detection, reduces healthcare costs, and broadens access to advanced diagnostics, especially in remote areas. The expanding diagnostic market is a significant driver for PCR machine adoption worldwide.
• Opportunities in Research and Academia: The expanding research sector, especially in genomics and molecular biology, is a major growth driver. PCR machines are essential for gene sequencing, mutation analysis, and drug development. Advances in high-throughput PCR and automation are increasing efficiency and data accuracy. Academic institutions and research labs are investing heavily in these technologies to accelerate scientific discoveries. This trend supports innovation, fosters collaborations, and boosts the overall market size for PCR equipment.
• Industrial and Forensic Applications: The industrial sector is increasingly utilizing PCR for quality control, food safety testing, and bioprocess monitoring. Forensic laboratories rely on PCR for DNA fingerprinting and criminal investigations. The demand for rapid, reliable, and sensitive PCR solutions in these fields is rising. Innovations such as real-time PCR and multiplexing are expanding the application scope. This diversification is creating new revenue streams and strengthening the market's resilience against sector-specific fluctuations.
• Advances in Automation and Data Integration: Automation is transforming PCR workflows, reducing manual errors, and increasing throughput. Integration with data management systems allows real-time analysis and remote monitoring. These technological improvements are making PCR machines more accessible and cost-effective for various users. Enhanced user interfaces and cloud connectivity facilitate better data sharing and collaboration. This evolution is driving market growth by enabling broader adoption across different sectors and improving operational efficiency.
• Expansion into Emerging Markets: Growing healthcare infrastructure and increasing awareness are driving PCR adoption in emerging economies. Manufacturers are developing affordable, portable PCR solutions tailored for resource-limited settings. Government initiatives and international aid programs are supporting deployment. This expansion opens new markets, boosts sales, and promotes global health initiatives. The increased accessibility of PCR technology in these regions is expected to significantly contribute to overall market growth and diversification.

These developments are significantly transforming the PCR machine market by enhancing diagnostic accuracy, expanding applications, and improving operational efficiency. The integration of automation and data management is making PCR technology more accessible and versatile. Growth in emerging markets and diverse sectors ensures sustained market expansion. Overall, these opportunities are fostering innovation, increasing adoption, and positioning PCR technology as a critical tool across healthcare, research, and industrial domains worldwide.

Strategic Growth Opportunities in the PCR Machine Market

The PCR machine market is experiencing rapid expansion driven by technological advancements, increasing demand for diagnostic testing, and growing applications in research and healthcare. As laboratories and medical facilities seek faster, more accurate, and cost-effective solutions, growth opportunities are emerging across various sectors. Companies are investing in innovation, expanding product portfolios, and entering new geographic markets to capitalize on this momentum. Understanding these key opportunities can help stakeholders strategize effectively for sustained growth and competitive advantage.

• Product Innovation and Technological Advancements: Continuous improvements in PCR machine technology, such as real-time PCR, digital PCR, and portable devices, are expanding application scope and enhancing performance. These innovations enable faster, more accurate results, and reduce costs, making PCR more accessible across clinical, research, and industrial sectors. Companies investing in R&D to develop next-generation PCR systems will likely capture significant market share and meet evolving customer needs.
• Growing Demand for Molecular Diagnostics: The rising prevalence of infectious diseases, cancer, and genetic disorders is fueling demand for molecular diagnostic tools, including PCR machines. Healthcare providers seek rapid, reliable testing methods for early diagnosis and personalized treatment. This trend is particularly prominent in emerging markets, where increasing healthcare infrastructure and awareness are driving adoption, creating substantial growth opportunities for PCR technology providers.
• Expansion in Research and Academic Sectors: The global research community's focus on genomics, personalized medicine, and biotechnology is boosting demand for PCR machines in academic and research institutions. The need for high-throughput, precise, and versatile PCR systems supports advancements in drug discovery, genetic research, and agricultural biotech. Collaborations between academia and industry, along with government funding, further accelerate market growth in this segment.
• Increasing Adoption in Industrial Applications: PCR technology is increasingly used in food safety testing, environmental monitoring, and bioprocessing. The ability to detect contaminants, pathogens, and genetic modifications quickly and accurately is vital for regulatory compliance and quality assurance. Industrial sectors are investing in PCR solutions to streamline operations, ensure safety, and meet stringent standards, opening new revenue streams for market players.
• Geographic Expansion into Emerging Markets: Rapid economic growth, rising healthcare investments, and increasing awareness of molecular diagnostics are driving PCR market expansion in Asia-Pacific, Latin America, and Africa. Local manufacturing, strategic partnerships, and tailored product offerings are enabling companies to penetrate these regions effectively. This geographic diversification reduces dependency on mature markets and unlocks significant growth potential in underserved areas.

The overall impact of these opportunities is a dynamic, expanding PCR market characterized by innovation, increased adoption across diverse sectors, and strategic geographic growth. Stakeholders who leverage these opportunities can enhance their market position, meet rising demand, and contribute to improved healthcare and research outcomes worldwide.

PCR Machine Market Driver and Challenges

The PCR machine market is influenced by a variety of technological, economic, and regulatory factors that shape its growth trajectory. Advances in molecular diagnostics, increasing demand for personalized medicine, and the need for rapid and accurate testing are key drivers. Additionally, supportive government policies and funding initiatives promote market expansion. However, challenges such as high equipment costs, regulatory hurdles, and technical complexities pose significant barriers. Understanding these drivers and challenges is essential for stakeholders to navigate the evolving landscape effectively and capitalize on emerging opportunities.

The factors responsible for driving the PCR machine market include:-

• Technological Advancements: The continuous development of more sensitive, faster, and user-friendly PCR technologies has significantly expanded market potential. Innovations like real-time PCR and digital PCR enable precise detection of genetic material, facilitating early diagnosis and personalized treatment. These advancements reduce turnaround times and improve accuracy, making PCR machines indispensable in clinical, research, and industrial settings. As technology evolves, costs decrease, and applications broaden, the market is expected to grow steadily. The integration of automation and miniaturization further enhances usability, attracting a wider user base and fostering innovation-driven growth.
• Rising Prevalence of Infectious Diseases: The increasing incidence of infectious diseases such as COVID-19, influenza, and tuberculosis has heightened demand for rapid diagnostic tools. PCR machines are crucial for detecting pathogens with high sensitivity and specificity, enabling timely intervention and containment. The pandemic underscored the importance of molecular diagnostics, leading to increased investments and adoption worldwide. This trend is expected to continue as emerging infectious diseases pose ongoing threats, prompting healthcare systems to prioritize molecular testing infrastructure. Consequently, the market benefits from heightened awareness and expanded deployment in public health and clinical laboratories.
• Growing Adoption in Personalized Medicine: The shift towards personalized medicine relies heavily on genetic analysis, where PCR plays a vital role. PCR machines facilitate gene expression analysis, mutation detection, and pharmacogenomics, enabling tailored treatment plans. The increasing prevalence of genetic disorders and cancer necessitates precise molecular diagnostics, driving demand for advanced PCR systems. Moreover, collaborations between biotech firms and healthcare providers foster innovation and expand application scope. As healthcare moves towards precision medicine, the PCR market is poised for substantial growth, supported by technological improvements and increasing clinical validation of molecular diagnostics.
• Expanding Research and Development Activities: The surge in biomedical research, genomics, and biotechnology initiatives fuels demand for PCR machines. Academic institutions, pharmaceutical companies, and research labs require reliable, high-throughput PCR systems for various applications, including drug development and genetic research. Government funding and grants further stimulate R&D activities, leading to product innovations and market expansion. The increasing focus on understanding genetic mechanisms and disease pathways enhances the need for sophisticated PCR technologies. This research-driven growth sustains market momentum and encourages manufacturers to develop more versatile and efficient PCR solutions.
• Increasing Healthcare Expenditure and Infrastructure Development: Rising healthcare spending and improved laboratory infrastructure support PCR market growth. Governments and the private sector invest in diagnostic facilities, especially in emerging economies, to enhance disease detection capabilities. The availability of funding for healthcare modernization enables widespread adoption of PCR technology in hospitals, clinics, and diagnostic labs. Additionally, the expansion of healthcare infrastructure facilitates large-scale testing during outbreaks and routine diagnostics. This financial and infrastructural support accelerates market penetration, ensuring PCR technology reaches a broader population and contributes to improved health outcomes.

The challenges facing this PCR machine market include:-

• High Equipment and Operational Costs: The initial investment for PCR machines remains substantial, especially for advanced real-time and digital PCR systems. Maintenance, reagent costs, and required technical expertise further add to operational expenses, limiting adoption among smaller clinics and laboratories with constrained budgets. This financial barrier hampers widespread deployment, particularly in developing regions. Manufacturers face pressure to reduce costs without compromising performance, which is critical for expanding market reach and ensuring affordability. Overcoming cost-related challenges is essential for broader adoption and sustained market growth.
• Stringent Regulatory and Validation Processes: The approval process for PCR-based diagnostic devices involves rigorous validation, clinical trials, and compliance with regulatory standards such as FDA, CE, and ISO. These procedures are time-consuming and costly, delaying product launches and increasing development risks. Regulatory hurdles can also vary across regions, complicating global market expansion. Ensuring quality, safety, and efficacy while navigating complex regulatory landscapes requires significant resources and expertise. Streamlining approval pathways and harmonizing standards are vital for accelerating innovation and market entry.
• Technical Complexity and Need for Skilled Personnel: Operating PCR machines and interpreting results demand specialized training and technical expertise. Variability in user proficiency can impact test accuracy and reliability. The complexity of assay design, sample preparation, and data analysis poses challenges for widespread adoption, especially in resource-limited settings. Additionally, maintaining equipment and troubleshooting technical issues requires skilled personnel, which may be scarce in certain regions. Addressing these technical barriers through user-friendly interfaces, automation, and training programs is crucial for expanding market accessibility and ensuring consistent diagnostic quality.

In summary, the PCR machine market is driven by technological innovations, rising disease prevalence, personalized medicine, research activities, and healthcare infrastructure development. However, high costs, regulatory complexities, and technical challenges pose significant hurdles. These factors collectively influence market dynamics, requiring stakeholders to innovate and adapt strategies to foster growth. The interplay of drivers and challenges will shape the future landscape, with opportunities for expansion balanced by the need to address barriers for broader adoption and sustainable development.

List of PCR Machine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies PCR machine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the PCR machine companies profiled in this report include-

• Thermo Fisher Scientific
• Roche
• Bio-Rad
• Qiagen
• Agilent
• Danaher
• Hangzhou Bioer
• Analytik Jena
• Techne
• Biosynex

PCR Machine Market by Segment

The study includes a forecast for the global PCR machine market by type, application, and region.

PCR Machine Market by Type [Value from 2019 to 2035]:

• Real-Time PCR
• Digital PCR
• Traditional PCR Machine
• Others

PCR Machine Market by Application [Value from 2019 to 2035]:

• Clinical
• Non-clinical

PCR Machine Market by Region [Value from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the PCR Machine Market

The PCR machine market has experienced significant growth driven by advancements in biotechnology, increased demand for diagnostic testing, and innovations in molecular biology. The COVID-19 pandemic accelerated the adoption of PCR technology worldwide, highlighting its importance in disease detection and research. Countries are investing heavily in research and development to improve PCR technology, enhance accuracy, and reduce costs. The market is also witnessing the integration of automation and digital solutions to streamline workflows. As healthcare systems evolve, the demand for reliable, rapid, and cost-effective PCR machines continues to rise globally, with key developments emerging across major economies.

• United States: The US market has seen rapid adoption of high-throughput PCR systems, driven by extensive research institutions and biotech companies. Innovations include digital PCR and real-time PCR advancements, improving sensitivity and speed. The government's focus on pandemic preparedness has increased investments in diagnostic infrastructure, boosting market growth. Companies are also developing portable PCR devices for point-of-care testing, expanding accessibility. Collaborations between tech firms and healthcare providers are fostering automation and data integration, enhancing diagnostic accuracy and efficiency.
• China: China's PCR market is expanding rapidly due to government initiatives supporting biotech innovation and healthcare infrastructure. The country has increased production capacity for PCR reagents and machines, reducing costs and improving availability. There is a strong focus on developing rapid, portable PCR devices for on-site testing, especially in rural areas. Domestic companies are investing in R&D to improve assay sensitivity and automation. The COVID-19 pandemic further accelerated adoption, with China becoming a major hub for PCR testing and manufacturing, positioning itself as a key player in the global market.
• Germany: Germany's PCR market is characterized by high-quality, precision instruments used primarily in clinical diagnostics and research. The country emphasizes regulatory compliance and product reliability, leading to innovations in automated and user-friendly PCR systems. German companies are investing in integrating AI and machine learning to enhance data analysis and workflow efficiency. The market benefits from strong collaborations between academia and industry, fostering the development of advanced PCR technologies. Additionally, Germany's focus on personalized medicine is driving demand for highly specific PCR assays for genetic and molecular diagnostics.
• India: India's PCR market is witnessing rapid growth due to increasing healthcare awareness and government initiatives to improve diagnostic capabilities. The demand for affordable, portable PCR machines is rising, especially in rural and semi-urban areas. Local manufacturers are expanding production capacities and focusing on cost-effective solutions to meet domestic needs. The COVID-19 pandemic significantly boosted market growth, with India becoming a major testing hub. R&D investments are also increasing, aiming to develop innovative, rapid PCR testing solutions suitable for resource-limited settings, further expanding market reach.
• Japan: Japan's PCR market is driven by advancements in medical research and the aging populations healthcare needs. The country emphasizes high-precision, automated PCR systems for clinical diagnostics and personalized medicine. Japanese firms are integrating AI and IoT technologies to improve diagnostic accuracy and workflow automation. The government's support for biotech innovation and aging-related health issues has spurred market growth. Additionally, Japan is focusing on developing portable PCR devices for point-of-care testing, especially for infectious diseases, ensuring rapid and reliable diagnostics in various healthcare settings.

Features of the Global PCR Machine Market

• Market Size Estimates: PCR machine market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
• Segmentation Analysis: PCR machine market size by type, application, and region in terms of value ($B).
• Regional Analysis: PCR machine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the PCR machine market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the PCR machine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the PCR machine market by type (real-time PCR, digital PCR, traditional PCR machine, and others), application (clinical and non-clinical), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global PCR Machine Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Real-Time PCR : Trends and Forecast (2019-2035)
• 4.4 Digital PCR : Trends and Forecast (2019-2035)
• 4.5 Traditional PCR Machine : Trends and Forecast (2019-2035)
• 4.6 Others : Trends and Forecast (2019-2035)

5. Global PCR Machine Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Clinical : Trends and Forecast (2019-2035)
• 5.4 Non-clinical : Trends and Forecast (2019-2035)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global PCR Machine Market by Region

7. North American PCR Machine Market

• 7.1 Overview
• 7.2 North American PCR Machine Market by Type
• 7.3 North American PCR Machine Market by Application
• 7.4 The United States PCR Machine Market
• 7.5 Canadian PCR Machine Market
• 7.6 Mexican PCR Machine Market

8. European PCR Machine Market

• 8.1 Overview
• 8.2 European PCR Machine Market by Type
• 8.3 European PCR Machine Market by Application
• 8.4 German PCR Machine Market
• 8.5 French PCR Machine Market
• 8.6 Italian PCR Machine Market
• 8.7 Spanish PCR Machine Market
• 8.8 The United Kingdom PCR Machine Market

9. APAC PCR Machine Market

• 9.1 Overview
• 9.2 APAC PCR Machine Market by Type
• 9.3 APAC PCR Machine Market by Application
• 9.4 Chinese PCR Machine Market
• 9.5 Indian PCR Machine Market
• 9.6 Japanese PCR Machine Market
• 9.7 South Korean PCR Machine Market
• 9.8 Indonesian PCR Machine Market

10. ROW PCR Machine Market

• 10.1 Overview
• 10.2 ROW PCR Machine Market by Type
• 10.3 ROW PCR Machine Market by Application
• 10.4 Middle Eastern PCR Machine Market
• 10.5 South American PCR Machine Market
• 10.6 African PCR Machine Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunity by Type
  • 12.2.2 Growth Opportunity by Application
• 12.3 Emerging Trends in the Global PCR Machine Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis Overview
• 13.2 Thermo Fisher Scientific
  • Company Overview
  • PCR Machine Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Roche
  • Company Overview
  • PCR Machine Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Bio-Rad
  • Company Overview
  • PCR Machine Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Qiagen
  • Company Overview
  • PCR Machine Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Agilent
  • Company Overview
  • PCR Machine Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Danaher
  • Company Overview
  • PCR Machine Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Hangzhou Bioer
  • Company Overview
  • PCR Machine Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Analytik Jena
  • Company Overview
  • PCR Machine Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Techne
  • Company Overview
  • PCR Machine Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Biosynex
  • Company Overview
  • PCR Machine Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us